Canada must move quickly for a successful rare disease strategy

There are still a few key pieces missing to ensure the 3.2 million Canadians living with rare diseases get faster access to the treatments they need.

Health Minister Jean-Yves Duclos speaks with reporters after a cabinet meeting in the West Block on May 30. We can show the world Canada is integral to finding solutions for the future of rare disease research and development, writes Gaby Bourbara. The Hill Times photograph by Andrew Meade

Opinion

BY GABY BOURBARA

June 12, 2023

In March 2023, Canada made a funding announcement for its national rare disease drug strategy, including $1.5-billion in new investments over three years. Canada’s commitment to enhancing public coverage for needed medications nationwide was welcomed by the rare disease co...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy